Medicare Enrolled

Dr. Zanetta Bryant, NP-C

Nurse Practitioner - Primary Care · Newnan, GA
Low-engagement
745 POPLAR RD, Newnan, GA 30265
4043673014
In practice since 2014 (12 years)
NPI: 1114332657 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bryant from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bryant? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bryant

Dr. Zanetta Bryant is a nurse practitioner - primary care in Newnan, GA, with 12 years of NPI registration.

Between the years covered by Open Payments, Dr. Bryant received a total of $10,133 from 56 pharmaceutical and/or device companies across 492 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - primary care. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bryant is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice $10,133 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,133
Total received (2021-2024)
Avg $2,533/year across 4 years
Top 2% in GA for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
492
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,133 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,490
2023
$2,693
2022
$3,165
2021
$2,785

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$318
Teva Pharmaceuticals USA, Inc.
$187
Novartis Pharmaceuticals Corporation
$165
UCB, Inc.
$128
Lilly USA, LLC
$106
Lundbeck LLC
$79
Alexion Pharmaceuticals, Inc.
$79
Neurocrine Biosciences, Inc.
$63
ARGENX US, INC.
$60
ABBVIE INC.
$58
Eisai Inc.
$41
Kyowa Kirin, Inc.
$38
ACADIA Pharmaceuticals Inc
$30
CATALYST PHARMACEUTICALS, INC.
$28
Boston Scientific Corporation
$27
CSL Behring
$25
SK Life Science, Inc.
$23
Kedrion Biopharma, Inc.
$18
Life Molecular Imaging Ltd
$18
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$924
UCB, Inc.
$798
SK Life Science, Inc.
$576
Novartis Pharmaceuticals Corporation
$501
MDD US Operations, LLC
$493
Neurocrine Biosciences, Inc.
$460
ARGENX US, INC.
$421
Teva Pharmaceuticals USA, Inc.
$419
ACADIA Pharmaceuticals Inc
$411
Kyowa Kirin, Inc.
$335
AbbVie Inc.
$329
Neurelis, Inc.
$304
Lilly USA, LLC
$293
Sunovion Pharmaceuticals Inc.
$292
Biohaven Pharmaceutical Holding Company Ltd.
$291
Amneal Pharmaceuticals LLC
$246
Biohaven Pharmaceuticals, Inc.
$203
Acorda Therapeutics, Inc
$193
Amgen Inc.
$184
Adamas Pharmaceuticals, Inc.
$164
PFIZER INC.
$164
EISAI INC.
$143
Avion Pharmaceuticals
$143
IMPEL PHARMACEUTICALS INC.
$134
Lundbeck LLC
$134
E.R. Squibb & Sons, L.L.C.
$125
CSL Behring
$116
JAZZ PHARMACEUTICALS INC.
$105
Supernus Pharmaceuticals, Inc.
$103
UPSHER-SMITH LABORATORIES LLC
$98
Catalyst Pharmaceuticals, Inc.
$81
Alexion Pharmaceuticals, Inc.
$79
Sumitomo Pharma America, Inc.
$74
IDORSIA PHARMACEUTICALS US INC
$72
Scilex Pharmaceuticals Inc.
$69
Otsuka America Pharmaceutical, Inc.
$64
Corium, LLC
$61
Biogen, Inc.
$56
AstraZeneca Pharmaceuticals LP
$53
GENZYME CORPORATION
$45
Eisai Inc.
$41
Grifols USA, LLC
$39
Alnylam Pharmaceuticals Inc.
$28
CATALYST PHARMACEUTICALS, INC.
$28
Boston Scientific Corporation
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Avanir Pharmaceuticals, Inc.
$22
Almatica Pharma LLC
$22
Celgene Corporation
$20
Merck Sharp & Dohme LLC
$20
EMD Serono, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$18
Kedrion Biopharma, Inc.
$18
Life Molecular Imaging Ltd
$18
OWP Pharmaceuticals, Inc.
$18
Allergan, Inc.
$14
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Albuked · Austedo XR · BELSOMRA · BOTOX · BRILINTA · Briviact · COMIRNATY · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · FYCOMPA · Fycompa · GOCOVRI · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LYVISPAH · Leqembi · MAVENCLAD · NAPRELAN · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OFEV · ONPATTRO · OXTELLAR XR · Ongentys · PAXLOVID · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYTARY · Rystiggo · Subvenite · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VRAYLAR · VYEPTI · VYVGART · XCOPRI · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for nurse practitioner - primary care in GA.

Looking for a nurse practitioner - primary care in Newnan?
Compare nurse practitioner - primary cares in the Newnan area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares within 10 mi
26
Per 100K population
17.3
County median income
$94,142
Nearest hospital
PIEDMONT NEWNAN HOSPITAL, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bryant is a nurse practitioner - primary care, with low-engagement industry engagement in the top 2% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Bryant receive payments from pharmaceutical companies?
Yes. Dr. Bryant received a total of $10,133 from 56 companies across 492 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Bryant) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →